CN105878277A - 生发、美发口服维生素胶囊 - Google Patents
生发、美发口服维生素胶囊 Download PDFInfo
- Publication number
- CN105878277A CN105878277A CN201610111980.1A CN201610111980A CN105878277A CN 105878277 A CN105878277 A CN 105878277A CN 201610111980 A CN201610111980 A CN 201610111980A CN 105878277 A CN105878277 A CN 105878277A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- hair
- zinc
- capsules
- hair growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003779 hair growth Effects 0.000 title claims abstract description 18
- 239000002775 capsule Substances 0.000 title claims abstract description 17
- 229940088594 vitamin Drugs 0.000 title claims abstract description 16
- 229930003231 vitamin Natural products 0.000 title claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 16
- 239000011782 vitamin Substances 0.000 title claims abstract description 16
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 15
- 230000001737 promoting effect Effects 0.000 title claims abstract description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 13
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000011701 zinc Substances 0.000 claims abstract description 9
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 5
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 5
- 229960000304 folic acid Drugs 0.000 claims abstract description 5
- 235000019152 folic acid Nutrition 0.000 claims abstract description 5
- 239000011724 folic acid Substances 0.000 claims abstract description 5
- 235000016709 nutrition Nutrition 0.000 claims abstract description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 5
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 3
- 229920002472 Starch Polymers 0.000 claims abstract description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 3
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 3
- 239000000194 fatty acid Substances 0.000 claims abstract description 3
- 229930195729 fatty acid Natural products 0.000 claims abstract description 3
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 3
- 239000001034 iron oxide pigment Substances 0.000 claims abstract description 3
- 239000011777 magnesium Substances 0.000 claims abstract description 3
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 3
- 229960002477 riboflavin Drugs 0.000 claims abstract description 3
- 239000008107 starch Substances 0.000 claims abstract description 3
- 235000019698 starch Nutrition 0.000 claims abstract description 3
- 229960003495 thiamine Drugs 0.000 claims abstract description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 3
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 3
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 3
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 3
- 239000011573 trace mineral Substances 0.000 claims description 7
- 235000013619 trace mineral Nutrition 0.000 claims description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 239000011720 vitamin B Substances 0.000 claims description 3
- 229940046001 vitamin b complex Drugs 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- IHBCFWWEZXPPLG-UHFFFAOYSA-N [Ca].[Zn] Chemical compound [Ca].[Zn] IHBCFWWEZXPPLG-UHFFFAOYSA-N 0.000 claims 1
- 229940100691 oral capsule Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 abstract description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 2
- 229930003756 Vitamin B7 Natural products 0.000 abstract 1
- 229960003966 nicotinamide Drugs 0.000 abstract 1
- 235000005152 nicotinamide Nutrition 0.000 abstract 1
- 239000011570 nicotinamide Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 235000011912 vitamin B7 Nutrition 0.000 abstract 1
- 239000011735 vitamin B7 Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明的目的是提供一种疗效快，治愈周期短，价格低的生发、美发口服维生素和微量元素胶囊。本发明是以如下技术方案实现的：每100g包含：食用胶、食用淀粉，烟酰胺(3.69g)硫酸锌(2.53g)或含等量锌的其他制剂泛酸钙(1.34g)脂肪酸镁，维生素B6(410mg)B2(328mg)，B1(287mg)叶酸(41mg)氧化钛、氧化铁色素，维生素H(30.7mg)维生素B12(205μg)药理：一粒生发、美发口服生发、美发口服维生素胶囊胶囊保证健康、浓密头发一天所需的维生素B族和锌的营养组合。
Description
技术领域
本发明是一种美发、治疗各种脱发疾病的生发口服营养素胶囊（维生素片），服用简单，一天一粒不易忘记，携带轻便。
背景技术
紧张、压力、单一的饮食或者环境污染能损伤您秀美的头发，造成干枯、脱发等。
一个变化多样的及均衡的营养对健康浓密的头发格外重要。
我们的饮食习惯不能一直保证足够的维生素和微量元素的需要。
目前，市场销售的有关生发药品，价格高，患者治疗费用高；种类多，患者选择繁杂。治疗效果不够理想，满足不了患者生发及普通女士、男士们健发、美发需要。
一粒生发胶囊（维生素片）保证健康、浓密头发一天所需的维生素B族和锌的营养组合。
发明内容
本发明的目的是提供一种疗效快，治愈周期短，价格低的生发口服维生素和微量元素胶囊（维生素片）。本发明是以如下技术方案实现的：每100g包含：
食用胶、食用淀粉，烟酰胺（3.69g）硫酸锌（2.53g）或含等量锌的其他制剂
泛酸钙（1.34g）脂肪酸镁，维生素B6（410mg）B2
（328mg），B1(287mg)叶酸（41mg）氧化钛、氧化铁色素，
维生素H（30.7mg）维生素B12(205µg)
本发明与现有技术相比具有如下优点和积极效果： 1、本发明具有养颜生发、疗效快，服用简单，便于携带；不易变质，便于保存。疗效显著。 2、价格低，可减轻患者的经济负担。3、配方精准、科学合理，无毒、无副作用。制作工艺简单易行。药理：
一粒生发胶囊（维生素片）保证健康、浓密头发所需的维生素B族和锌的营养组合。
锌参与许多细胞物质交换过程并促进健康秀发和指甲生长的过程。
泛酸和7种维生素B族协调重要的机体物质交换和头发的顺畅地生长。
生物素（维生素H）对头发结构核心成分的角质蛋白的构建起到重要的作用。
餐后，每天一粒生发胶囊（维生素片）同足量液体口服。一般服用营养素一两周即长出新发，明显感到头发生长加速，几个月后头发变得浓郁，且指甲光亮。
具体实施方式：
实施例1
步骤一：将维生素或微量元素使用适合的包衣液在造粒机中制备肠溶微胶囊。已经微囊化的维生素、微量元素单体稳定性好，不易降解，不互相干扰，减少氧化，能保持其固有的生理活性。
维生素或微量元素微囊化小丸也可以从制造商购买。
步骤二：按如下配合比例将维生素或微量元素微囊化小丸混合装入可食用的胶囊内。使之成为生发、美发口服维生素胶囊。
实施例2
或者按如下配合比例将维生素及微量元素经过原料混合、制软料、制粒、干燥、整粒、总混、制片等步骤制成生发、美发口服维生素片。
营养成分 每粒含量 占日需比例
维生素B1 1.4mg 100%
维生素B2 1.6mg 100%
维生素B6 2.0mg 100%
维生素B12 1.0µg 100%
锌 5.0mg 33%
泛酸 6.0mg 100%
维生素H 150µg 100%
烟酸 18mg NE 100%
叶酸 200µg 100%。
Claims (2)
1.一种生发、美发口服维生素和微量元素胶囊（维生素片），其特征在于是由下述重量比例的组分组成的：
每100g包含：
食用胶、食用淀粉，烟酰胺（3.69g）硫酸锌（2.53g）或含等量锌的其他制剂
泛酸钙（1.34g）脂肪酸镁，维生素B6（410mg）B2
（328mg），B1(287mg)叶酸（41mg）氧化钛、氧化铁色素，
维生素H（30.7mg）维生素B12(205µg)。
2.如权利要求1所述的一种生发口服维生素和微量胶囊（维生素片），其特征在于其制备方法是：
将上述配比的组分制成口服胶囊（维生素片）
营养成分 每粒含量 占日需比例
维生素B1 1.4mg 100%
维生素B2 1.6mg 100%
维生素B6 2.0mg 100%
维生素B12 1.0µg 100%
锌 5.0mg 33%
泛酸 6.0mg 100%
维生素H 150µg 100%
烟酸 18mg NE 100%
叶酸 200µg 100%
一粒生发胶囊（维生素片）保证健康、浓密头发一天所需的维生素B族和锌的营养组合。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610111980.1A CN105878277A (zh) | 2016-02-29 | 2016-02-29 | 生发、美发口服维生素胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610111980.1A CN105878277A (zh) | 2016-02-29 | 2016-02-29 | 生发、美发口服维生素胶囊 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105878277A true CN105878277A (zh) | 2016-08-24 |
Family
ID=57013798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610111980.1A Pending CN105878277A (zh) | 2016-02-29 | 2016-02-29 | 生发、美发口服维生素胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105878277A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023004690A1 (zh) * | 2021-07-29 | 2023-02-02 | 山东赛珥医药科技有限公司 | 一种抗氧化营养组合胶囊 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1539445A (zh) * | 2003-04-22 | 2004-10-27 | 吴新胜 | 一种用于生发乌发的中西药复方制剂 |
| CN1620287A (zh) * | 2002-02-01 | 2005-05-25 | 朱利亚尼股份公司 | 防止脱发用药物或食疗用途组合物 |
| CN101254208A (zh) * | 2008-01-04 | 2008-09-03 | 周成富 | 一种治疗脱发的组合物 |
| US20110287061A1 (en) * | 2010-05-20 | 2011-11-24 | Cathy Beggan | Dietary composition and method for promoting healthy hair growth and melanogenesis |
| EP2703003A1 (en) * | 2012-08-31 | 2014-03-05 | Probelte Biotecnologia S.L. | A pomegranate extract and compositions containing pomegranate polyphenols for treating or preventing diseases or physiopathological conditions associated with an excessive gene expression and/or physiological activity of interleukin-6 |
-
2016
- 2016-02-29 CN CN201610111980.1A patent/CN105878277A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1620287A (zh) * | 2002-02-01 | 2005-05-25 | 朱利亚尼股份公司 | 防止脱发用药物或食疗用途组合物 |
| CN1539445A (zh) * | 2003-04-22 | 2004-10-27 | 吴新胜 | 一种用于生发乌发的中西药复方制剂 |
| CN101254208A (zh) * | 2008-01-04 | 2008-09-03 | 周成富 | 一种治疗脱发的组合物 |
| US20110287061A1 (en) * | 2010-05-20 | 2011-11-24 | Cathy Beggan | Dietary composition and method for promoting healthy hair growth and melanogenesis |
| EP2703003A1 (en) * | 2012-08-31 | 2014-03-05 | Probelte Biotecnologia S.L. | A pomegranate extract and compositions containing pomegranate polyphenols for treating or preventing diseases or physiopathological conditions associated with an excessive gene expression and/or physiological activity of interleukin-6 |
Non-Patent Citations (3)
| Title |
|---|
| 艾尔.敏德尔，哈特.莫狄斯: "《新维生素圣经》", 30 September 2015 * |
| 邢攸军: "甘草锌胶囊联合谷维素片、复合维生素Ｂ片治疗斑秃８例", 《医学理论与实践》 * |
| 陈红，孙建枢: "养血生发胶囊的微量元素测定与其药效的相关性分析", 《中医药研究》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023004690A1 (zh) * | 2021-07-29 | 2023-02-02 | 山东赛珥医药科技有限公司 | 一种抗氧化营养组合胶囊 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102038691B (zh) | 一种维生素氨基酸的复合制剂及其制备方法 | |
| CN105410943A (zh) | 一种复合维生素片及其制备方法 | |
| CN103734507A (zh) | 一种发酵制备蛋鸡饲料的方法 | |
| CN103815227A (zh) | 一种复合维生素红糖组合物及其应用 | |
| CN1961715A (zh) | 狐皮毛营养增强剂 | |
| JP2015007092A (ja) | 大量の栄養補給剤の負の副作用なしに、環境ストレスの作用に対抗し、免疫を改善し、活動力を改善し、一方でビタミンおよび無機質の欠乏に対処するための、マルチビタミン／無機質配合物 | |
| CN106359964A (zh) | 猪饲料及其制备方法 | |
| CN105878277A (zh) | 生发、美发口服维生素胶囊 | |
| CN102960602A (zh) | 一种芦荟保健粉 | |
| CN102028230B (zh) | 一种保健品辅料及其应用 | |
| CN106165869A (zh) | 一种改善记忆功能的保健食品及其制备方法 | |
| CN103621871B (zh) | 一种复合氨基酸保健品及其制备方法 | |
| FR2861594A1 (fr) | Composition contenant un extrait de the vert et de la vitamine c | |
| CN104397719A (zh) | 玛咖片及其制备方法 | |
| CN109043545A (zh) | 一种复合生物素营养制剂及其制备方法、应用 | |
| CN107789444A (zh) | 一种宠物犬亮毛维生素软胶囊组方及其制备方法 | |
| CN105962325A (zh) | 一种女士型多种维生素钙铁锌硒片 | |
| CN106361775B (zh) | 一种成年女性营养素及其制作方法 | |
| CN101156686A (zh) | 一种含超氧化物歧化酶的营养剂 | |
| CN103417960A (zh) | 一种芋头粉保健胶囊 | |
| CN108851058A (zh) | 一种富含α-亚麻酸的多种维生素矿物质软胶囊及其制备方法 | |
| CN102318832A (zh) | 一种提高机体耐缺氧能力的营养剂 | |
| CN102048221A (zh) | 一种营养饮料 | |
| CN101874570B (zh) | 一种宠物食品的外表面喷涂营养组合物及其喷涂方法 | |
| CN106306179A (zh) | 一种降血糖、血脂、血压的养生普洱茶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160824 |
|
| WD01 | Invention patent application deemed withdrawn after publication |